Cited by 164Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlVestibular and auditory disorders

Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study

Open access
PEREZ‐LUGONES, ALEJANDRO, SCHWEIKERT, ROBERT, PAVIA, STEPHEN, SRA, JASBIR, AKHTAR, MASOOD, JAEGER, FREDRICK, TOMASSONI, GERY F., SALIBA, WALID +6 more·2001·Journal of Cardiovascular Electrophysiology

Abstract

Midodrine for Neurocardiogenic Syncope. Introduction: The efficacy of midodrine for the management of patients with neurocardiogenic syncope was assessed prospectively in a randomized control study. Methods and Results: Patients who had at least monthly occurrences of syncope and a positive tilt‐table test were included in the study. A total of 61 patients were randomly allocated to treatment either with midodrine or with fluid, salt tablets, and counseling. Midodrine was given at a starting dose of 5 mg three times a day and increased up to a dose of 15 mg three times a day when required. Midodrine was given during the daytime every 6 hours. Thirty‐one patients were assigned to treatment with midodrine; the other 30 patients were advised to increase their fluid intake and were instructed to recognize their prodromes and abort the progression to syncope. Patients were followed‐up for at least 6 months. A quality‐of‐life questionnaire was administered at the time of randomization and 6 months after. At the 6‐month follow‐up, 25 (81%) of 31 midodrine‐treated patients and 4 (13%) of the 30 fluid‐therapy patients had remained asymptomatic (P < 0.001). One patient had to discontinue taking midodrine due to severe side effects and another six patients experienced minor side effects that did not require drug discontinuation. Conclusion: Midodrine appeared to provide a significant benefit in patients with neurocardiogenic syncope. To prevent recurrence of symptoms, dose adjustments were required in about one third of patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1540-8167.2001.00935.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [1]1. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A: For vasovagal syncope international study (VASIS) investigators. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. Circulation 1999;99:1452-1457.
  2. [6]6. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S, Blanck Z, Akhtar M: Ef cacy of different treatment strategies for neurocar- diogenic syncope. PACE 1995;18:655-662.
  3. [7]7. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D: A controlled trial of acute and long term medical therapy in tilt- induced neurally mediated syncope. Am J Cardiol 1992;70:339-342.
  4. [10]10. Fitzpatrick A, Ahmed R, Williams S, Sutton R: A randomized trial of medical therapy in "malignant vasovagal syncope" or "neurally-me- diated bradycardia/hypotension syndrome." Eur J Cardiol EP 1991;2: 99-102.
  5. [11]11. McTavish D, Goa K: Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and second- ary hypotensive disorders. Drugs 1989;38:757-777.

Cited by

Sorted by citations

Authors
PEREZ‐LUGONES, A., SCHWEIKERT, R., PAVIA, S., SRA, J., AKHTAR, M., JAEGER, F., TOMASSONI, G. F., SALIBA, W., LEONELLI, F. M., BASH, D., BEHEIRY, S., SHEWCHIK, J., TCHOU, P. J., & NATALE, A.
Affiliations
  • Cleveland Clinic (US)
  • Central Baptist Hospital (US)
Corresponding author
NATALE, ANDREA
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2001-08
Volume
12
Issue
8
Pages
935-938
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W2145507145
Cited by
164
References
9
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 7 · 2020: 3 · 2018: 5 · 2017: 10 · 2016: 2 · 2015: 7 · 2014: 8 · 2013: 8 · 2012: 11
FWCI
8.25
Type
journal article
Language
en
Open access
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
Keywords
midodrine, vasovagal syncope, tilt table test, quality of life, adverse drug reactions, dose adjustment, syncope prevention
MeSH terms
Adrenergic alpha-Agonists, Adult, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, Kentucky, Male, Middle Aged, Midodrine, Prospective Studies, Quality of Life, Surveys and Questionnaires, Recurrence, Severity of Illness Index, Wisconsin, Treatment Outcome, Syncope, Vasovagal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review